Article

NYU Doctors Explain DCIS

Last month, we got the chance to discuss DCIS with three doctors from NYU Cancer Center: Dr. Deborah Axelrod, Dr. Julia Smith, and Dr. David Kleinberg.

Last month, we got the chance to discuss DCIS with three doctors from NYU Cancer Center: Dr. Deborah Axelrod, Dr. Julia Smith, and Dr. David Kleinberg.

They explain what DCIS is, discuss public trials and future directions for DCIS, and address some current controversies around the diagnosis.

Listen to the talk here:

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.
Image of women, with text.
Image of Dr. with text.
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Related Content
Image of woman.
July 11th 2025

Facing Breast and Lung Cancer Led Me to a New Purpose in Life

Sue McCarthy
I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive changes in my life.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Karen Cohn is a retired middle school special education teacher who was diagnosed with follicular lymphoma in July 2020. Catch up on all of Karen's blogs here!
July 11th 2025

Five Years Since My Lymphoma Diagnosis: What I Know Now

Karen Cohn
Five years after my lymphoma diagnosis, life looks normal on the outside; however, the fear of recurrence and the reality of cancer never fully fade.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
The FDA granted FTD to TRE-515 & radioligand therapy for PSMA+ mCRPC: © stock.adobe.com.
July 11th 2025

Fast Track Status Granted by FDA to TRE-515 in Prostate Cancer

Spencer Feldman
The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic castration-resistant prostate cancer.
Image of women.
July 10th 2025

Diagnosis Day: What I Felt, What I Learned

Patti McGee
I found a lump and was shocked to learn it was breast cancer, but over 22 years I’ve learned healing takes time, asking for help is strength, and hope grows.